While many dispensers are medicine boxes only, the Evondos medicine dispensing robot enables two-way communication between nurses and patients. Nurses can reach patients remotely by, for instance, sending reminders to eat or drink, whereas patients may send out automatic replies. The robot tells nurses whether the medication has been received timely, and the dispenser can be preset according to the patient’s personal medication regimen.
The next stage of international growth with Verdane
According to the Financial Times’ FT 1000 2021 ranking, Evondos is one of the fastest growing companies in Europe. Currently, the company employs 115 professionals in Finland, Sweden, Norway and Denmark. This year, sales are estimated to grow by 50% and personnel by 30%, and Evondos is also investing significantly in R&D.
“We have a motivated and high-performing team, a highly professional Board of Directors that has provided us with clear-cut priorities, and a steady market position. Currently, we are focusing on expanding internationally and searching for potential technology partners,” says Koski.
Verdane announced its investment in Evondos in spring 2020. The growth partnership with Verdane aims to develop Evondos’ service offering and extend Evondos’ market leadership beyond the Nordic market.
“The most important thing I have learned is to stay focused and get results. When a company is still young, you cannot do everything. You must set priorities and earn the trust of investors and partners. I was advised not to focus on the operating margin or EBITDA but to rather boldly take forward looking stance to achieve constant high growth rates. I’m really looking forward to our coming years with Verdane”, says Koski.